GlassScriptPhysician profile
Calvin A Ridgeway
NPI 1184718579
$6,522.07
in general payments reported to CMS, 2019-2025
14 companies · $406 in 2025
The $406 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,127 · 2021: $128 · 2022: $13.97 · 2023: $131 · 2024: $716 · 2025: $406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,181 · Entertainment: $63.27 · Education: $8.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,181.19 |
| Entertainment | $63.27 |
| Education | $8.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardinal Health 414 LLC | $4,900.00 | 2019 | |
| Endomagnetics LTD | $370.55 | 2019-2024 | Magseed, Magtrace |
| Hologic Sales and Service, LLC | $266.55 | 2024 | Localizer, Trunode, Trident Specimen Radiography System |
| Merck Sharp & Dohme LLC | $224.22 | 2023-2025 | Keytruda, Bridion, Lynparza |
| Stryker Corporation | $187.47 | 2019-2023 | Stryker |
| Dilon Technologies, INC. | $170.86 | 2024-2025 | Hemoblast Bellows |
| Carl Zeiss Meditec USA, INC. | $117.87 | 2024 | Iort, Intrabeam |
| Merit Medical Systems INC | $102.71 | 2021 | |
| Kub Technologies INC. | $63.27 | 2023 | Mozart |
| Novartis Pharmaceuticals Corporation | $31.94 | 2025 | |
| Applied Medical Resources Corporation | $31.55 | 2025 | Gelpoint Advanced Access Platform |
| Elucent Medical | $25.11 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $16.00 | 2024 | Enhertu |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Calvin Ridgeway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.